EOM 1352: Fri 7 June 2024, 11:36

Current Edition

Discovery Park: Wed 13 November 2024, 10:35
ramusmedical
FDA Inspection Close Up – Using Strong Process Mapping and Gap Analysis
Editorial Archive

FDA Inspection Close Up – Using Strong Process Mapping and Gap Analysis

FDA Inspection Close Up - Using Strong Process Mapping and Gap Analysis An FDA regulatory inspection is an activity of verification. It serves to give the FDA the as...
Continue Reading →
Risk Mitigation and Due Diligence in Overcoming Lost to Follow-up [LTFU] Subjects in a Clinical Trial
Editorial Archive

Risk Mitigation and Due Diligence in Overcoming Lost to Follow-up [LTFU] Subjects in a Clinical Trial

Risk Mitigation and Due Diligence in Overcoming Lost to Follow-up [LTFU] Subjects in a Clinical Trial The term ‘lost to follow-up’ describes a patient who has premat...
Continue Reading →
Enhancement of Regulatory Procedures on Medicinal Products in Serbia – Patients Information Requirements
Editorial Archive

Enhancement of Regulatory Procedures on Medicinal Products in Serbia – Patients Information Requirements

Enhancement of Regulatory Procedures on Medicinal Products in Serbia – Patients Information Requirements Providing reliable information on medicinal products to prof...
Continue Reading →
Health Economics and Multinational Randomised Controlled Trials
Editorial Archive

Health Economics and Multinational Randomised Controlled Trials

Health Economics and Multinational Randomised Controlled Trials Collecting clinical efficacy and safety data in multinational randomised controlled trials (MNRCTs) ha...
Continue Reading →
Catalyst: Fri 8 November 2024, 14:16
Biosynth: Wed 13 November 2024, 10:18